Bausch + Lomb Separates From Bausch Health After Delivering Its Only First-Quarter Sales Growth

Bausch Health closed Bausch + Lomb IPO offering 10% of shares instead of 20% planned. Bausch + Lomb’s $889m Q1 revenue up 1% while other Bausch Health divisions slumped.